<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E5AB7E3C-876B-4608-8B8A-C7EC86B34584"><gtr:id>E5AB7E3C-876B-4608-8B8A-C7EC86B34584</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Turner</gtr:surname><gtr:orcidId>0000-0002-3801-9896</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FB%2F0000H322"><gtr:id>2FFC327C-22F9-4256-9A83-266804F1104C</gtr:id><gtr:title>Identification of te RNA targets of the TIS11b and d tumour suppressors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/B/0000H322</gtr:grantReference><gtr:abstractText>The control of mRNA stability and translation is widely used by cells to control proliferation, differentiation and apoptosis. The importance of post-transcriptional control is underscored by observations that it is deregulated in malignant diseases including leukaemia and lymphoma. However, our understanding of post-transcriptional control mechanisms, and their relevance to cancer, lags far behind our understanding of transcriptional regulation and signal transduction. Post transcriptional control is an area of investigation that has been relatively neglected in the search for an understanding of oncogenic mechanisms and novel routes to therapy. This proposal seeks to further our understanding of how RNA binding proteins (RBP) regulate fundamental cellular processes and how they are integrated with signaling and transcriptional processes which may be corrupted in cancer.</gtr:abstractText><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2011-07-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>45540</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Interest in our work has led to the development of a collaboration with Cancer Research Technology and Celgene</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>58FF23F6-690E-434E-B8A7-152355CF63D1</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56b36545b3ad39.08489534</gtr:outcomeId><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>mechanisms controlling cell division. see the published papers for details.

also

http://www.babraham.ac.uk/news/2016/04/quiescence-B-cells</gtr:description><gtr:exploitationPathways>anti-cancer therapy</gtr:exploitationPathways><gtr:id>CF774327-ED8B-4D60-88D2-48DB9AA52159</gtr:id><gtr:outcomeId>56b3673e80ebe5.07810094</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.babraham.ac.uk/news/2016/04/quiescence-B-cells</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>562DAD7A-CF7E-4365-A44C-A5A090AA0685</gtr:id><gtr:title>Cell cycle RNA regulons coordinating early lymphocyte development.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. RNA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8990ce80a28677e7463d99b5ba4fb"><gtr:id>04c8990ce80a28677e7463d99b5ba4fb</gtr:id><gtr:otherNames>Galloway A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1757-7004</gtr:issn><gtr:outcomeId>5a8313047e2823.45877684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02F8D55A-6D1D-4DAE-9278-2C6A1035DA07</gtr:id><gtr:title>The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a3be441d5d9a71a8aedfd659f613286"><gtr:id>3a3be441d5d9a71a8aedfd659f613286</gtr:id><gtr:otherNames>Vogel KU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58ac052f9f1655.69930000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EAC18BB-2DBB-4FB7-8FF6-07E82DCD3A4B</gtr:id><gtr:title>RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04c8990ce80a28677e7463d99b5ba4fb"><gtr:id>04c8990ce80a28677e7463d99b5ba4fb</gtr:id><gtr:otherNames>Galloway A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>58ac0530009c59.13314781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40D8FA06-BBD0-415F-A971-8978F2A560A3</gtr:id><gtr:title>Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80276f81556671d380e40627c11b5180"><gtr:id>80276f81556671d380e40627c11b5180</gtr:id><gtr:otherNames>Newman R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5a83130680b401.56336111</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/B/0000H322</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>